Eritoran Tetrasodium and Placebo in Patients/Severe Sepsis

ID Number 06-0726

Principal Investigator(s)
Roopa Kohli-Seth

Department(s) or Division(s)

The purpose of this research study is to find out whether Eritoran Tetrasodium (Eritoran) is safe and helpful in treating patients with severe sepsis (a potentially life-threatening infection).

Contact Information
Rosanna Del Giudice, RN
(212) 241-3149

Recruiting Patients: Yes